← All trials
NCT05347069
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 14, 2022
- Primary completion
- Mar 31, 2030
- Completion date
- Dec 31, 2030
- First posted
- Apr 26, 2022
- Last posted
- Aug 17, 2022
- Enrollment
- 2890
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kyoto UniversityLead sponsor
- Kyoto UniversityOverall official - principal investigator
- Kyoto UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.